TrademarkDir
TERLIVAZ TERLIPRESSIN FOR INJECTION
LIVE

Serial Number

88900093

Owner

Mallinckrodt Hospital Products IP Limited

Attorney

Camille M. Miller

First Use Date

Oct 12, 2022

Filing Date

May 4, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TERLIVAZ TERLIPRESSIN FOR INJECTION Trademark

Serial Number: 88900093 • Registration: 7081079

TERLIVAZ TERLIPRESSIN FOR INJECTION is a trademark filed by Mallinckrodt Hospital Products IP Limited on May 4, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Mallinckrodt Hospital Products IP Limited

Damastown Industrial Estate,

Entity Type: 99

MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED (58 trademarks)

COLLEGE BUSINESS & TECHNOLOGY PARK,
BLANCHARDSTOWN D15 TX2V, , IE

Entity Type: 77

Trademark Details

Filing Date

May 4, 2020

Registration Date

June 13, 2023

First Use Anywhere

October 12, 2022

First Use in Commerce

October 12, 2022

Published for Opposition

September 8, 2020

Goods & Services

Pharmaceutical preparations for the treatment of hepatorenal syndrome (HRS)

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 13, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 13, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 13, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 13, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 13, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 13, 2026 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 13, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 13, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 9, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 7, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 21, 2023 SUPC
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 4, 2023 ASGN
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 28, 2022 ASCK
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 21, 2022 AITU
USE AMENDMENT FILED
Nov 1, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 1, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 6, 2022 EXRA
SOU EXTENSION 3 GRANTED
Apr 4, 2022 EX3G
SOU EXTENSION 3 FILED
Apr 4, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 4, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 8, 2021 EXRA
SOU EXTENSION 2 GRANTED
Oct 6, 2021 EX2G
SOU EXTENSION 2 FILED
Oct 6, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 6, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 21, 2021 EXRA
SOU EXTENSION 1 GRANTED
Apr 19, 2021 EX1G
SOU EXTENSION 1 FILED
Apr 19, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 19, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 3, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 5, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 5, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 5, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 5, 2020 CNEA
ASSIGNED TO EXAMINER
Jul 29, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 16, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2020 NWOS
NEW APPLICATION ENTERED
May 7, 2020 NWAP

Related Trademarks

More from this Owner

TERLIVAZ

TERLIVAZ

TERLIVAZ

TERLIVAZ

TERLIVAZ

TERLIVAZ

TERLIVAZ

TERLIVAZ

TERLIVAZ

TERLIVAZ

H.P. ACTHAR GEL

H.P. ACTHAR GEL